• G6pd And Malaria Drugs
• Article Malaria Pdf
• G6pd Malaria Treatment

G6pd And Malaria Drugs

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria‑infected patients. Tag: g6pd Primaquine. Primaquine is the essential co-drug with chloroquine in treating all cases of malaria. It is highly effective against the gametocytes of all plasmodia and thereby prevents spread of the disease to the mosquito from the patient. It is also effective against the dormant tissue forms of P.

G6PD Deficiency has been said to provide resistance against malaria infection. This concept was first examined after scientists noticed a similarity between areas of the world where G6PD Deficiency is prevalent and malaria infested areas. G6PD Deficiency Reference Guide What is G6PD Deficiency? Medications to Avoid Analgesics / Antipyretics acetanilid, acetophenetidin (phenacetin). G6PD Deficiency is an inherited condition; therefore, you can not get it from being in contact with someone who has G6PD Deficiency. Since it is inherited, there is no cure.

In his valuable review on genetics of malaria resistance, ) tackles the interesting issue of the protection against Plasmodium falciparum afforded by G6PD deficiency. Specifically, he quotes data from a study () conducted in Gambia and in Kenya, from which it was claimed that the degree of protection was similar in hemizygous G6PD-deficient males and in heterozygous G6PD-deficienct females. ) points out that this is rather paradoxical, because it would lead to fixation of the G6PD-deficient allele(s), which does not seem to have taken place; and he reproduces from that paper a figure that offers an explanation on the basis of an ad-hoc hypothesis.

) has not made mention of a previous study of 699 children () in which, based on the distribution of P. falciparum parasitaemia values in children in Southwestern Nigeria, we reported that there was significant protection of girls heterozygous for G6PD deficiency, whereas we did not find the same in hemizygous G6PD-deficient boys. Thus, these data are fully compatible with balanced polymorphism at or near equilibrium.

Although this is not mentioned in Hedrick's review, it has now been found () that the most common G6PD deficiency allele in the Gambia is G6PD A− having the two mutations N126D and L323P, and not G6PD A− having the two mutations N126D and M68V. Although both of these alleles were known since 1989 (), only the latter was tested for in the study by on the assumption that the frequency of the former would be negligible. As a result, we can estimate that in the Gambia component of the study, about two-thirds of the G6PD-deficient samples were misclassified as normal; this leaves the Kenya component of the study, consisting of a group of 935 children, within which the differences observed did not reach statistical significance.

It is not clear why the paper by was ignored. If the reason was because it did not include molecular analysis (the G6PD gene was not cloned until several years later: ), this was not a good reason, because robust genotypic classification was obtained in that study by combining no less than three independent methodologies. The reliability of our genotypic classification was confirmed by the fact that the data were in Hardy–Weinberg equilibrium. It is paradoxical that the review missed this study, which had incorporated deliberate safeguards against genotype misclassification; and if more than one type of G6PD A− had been present in the population sample, this would not have affected the results, because by the methods used, all types of G6PD A− were identified.

Article Malaria Pdf

Bennett (1958) pointed out that increased fitness of heterozygotes is not in itself either necessary or sufficient for reaching equilibrium under selection at an X-linked locus; this depends on the fitness values of the other genotypes. However, in the case of G6PD deficiency, there is every reason to assume that the fitness of normal male hemizygotes is the same as that of normal female homozygotes, and that the fitness of G6PD-deficient male hemizygotes is the same as that of G6PD-deficient female homozygotes. Under these conditions, it has been pointed out by Haldane and Jayakar (1964) and by ) that the female heterozygote must be the genotype with the highest fitness.

There is no a priori certainty that, in any particular population, the G6PD polymorphism must be at equilibrium. In principle, malaria selection could ultimately cause fixation of a G6PD deficiency allele. However, this is not very likely, because (a) this has not happened in any population, even with holoendemic malaria as in Nigeria, and (b) both P. falciparum malaria endemicity and G6PD deficiency A− are estimated () to be at least 5000 years old (corresponding to some 200 generations). To obtain evidence on genetic protection against malaria is not easy, in part because the differences in fitness associated with individual genotypes may be small; therefore, it is probably best to consider all independent studies (for instance, in addition to those already mentioned, that by ). At the present state of knowledge, two independent studies (; ) in two different populations, nearly 40 years apart, are consistent, with G6PD deficiency A− being a balanced polymorphism with heterozygote advantage.

G6pd Malaria Treatment

References

• Bennett JH. The existence and stability of selective balance polymorphism at sex-linked loci. Australian J Biol Sci. 1958;11:598–602.[Google Scholar]
• Beutler E, Kuhl W, Vives-Corrons JL, Prchal JT. Molecular heterogeneity of glucose 6-phosphate dehydrogenase A- Blood. 1989;74:2550–2555. [PubMed] [Google Scholar]
• Bienzle U, Ayeni O, Lucas AO, Luzzatto L. Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant. Lancet. 1972;1:107–110. [PubMed] [Google Scholar]
• Clark TG, Fry AE, Auburn S, Campino S, Diakite M, Green A, et al. Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet. 2009;17:1080–1085.[PMC free article] [PubMed] [Google Scholar]
• Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med. 2007;4:e66.[PMC free article] [PubMed] [Google Scholar]
• Haldane JBS, Jayakar SD. Equilibria under natural selection. J Genet. 1964;59:29–36.[Google Scholar]
• Hedrick PW. 2011. Population genetics of Malaria resistance in humans. Heredity107283–304. [PMC free article] [PubMed]
• Kirkman NH. Properties of X-linked alleles during selection. Am J Hum Genet. 1966;18:424–432.[PMC free article] [PubMed] [Google Scholar]
• Persico MG, Viglietto G, Martini G, Toniolo D, Paonessa G, Moscatelli C, et al. 1986Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5′ non-coding region Nucleic Acids Res142511–2522.7822. [PMC free article] [PubMed] [Google Scholar]
• Ruwende C, Khoo SC, Snow RW, Yates SN, Kwiatkowski D, Gupta S, et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature. 1995;376:246–249. [PubMed] [Google Scholar]
• Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science (New York, NY) 2001;293:455–462. [PubMed] [Google Scholar]